(Q38181857)

30 August 2017

title

Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children (English)

1 reference

30 August 2017

0 references

1 reference

N Foolad

1

1 reference

30 August 2017

A W Armstrong

series ordinal

2

1 reference

30 August 2017

language of work or name

1 reference

1 June 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

5

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

151-160

1 reference

Lactic acid bacteria and human clinical infection

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Microflora-associated characteristics in faeces from allergic and nonallergic infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Overview of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

New aspects of probiotics--a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotic bacteria in the management of atopic disease: underscoring the importance of viability

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Demonstration of safety of probiotics -- a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0034

21 January 2018

Identifiers

DOI

10.3920/BM2013.0034

1 reference

30 August 2017

1 reference